T. Rowe Price Associates, Inc. 13D and 13G filings for Orchestra BioMed Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 10:03 am Sale | 2023-12-31 | 13G | Orchestra BioMed Holdings, Inc. OBIO | T. Rowe Price Associates, Inc. | 622,608 1.700% | -63,193 (-9.21%) | Filing |
| 2023-02-14 12:38 pm Purchase | 2022-12-31 | 13G | Orchestra BioMed Holdings, Inc. OBIO | T. Rowe Price Associates, Inc. | 685,801 6.100% | 685,801 (New Position) | Filing |